Anti-hyperglycaemic activity of IND 01 and its interaction with glyburide and pioglitazone in alloxan induced diabetic mice

International Journal of Diabetes and Metabolism

Volumn 17, Issue 1, 2009, Pages 21-26

  Shitole, Prasad P ^a   Badole, Sachin L ^a   Bodhankar, Subhash L ^a   Mohan, V ^b   Bhaskaran, Sunil ^b  

^a BHARATI VIDYAPEETH DEEMED UNIVERSITY   (India)

^b Indus Biotech Private Ltd   (India)

Author keywords

Antihyperglycaemic; Glyburide; IND 01; OGTT; Pioglitazone

Indexed keywords

4 HYDROXYISOLEUCINE; ALLOXAN; ANTIDIABETIC AGENT; GALACTOMANNAN; GLIBENCLAMIDE; GLUCOSE; IND 01; PIOGLITAZONE; TRIGONELLINE; UNCLASSIFIED DRUG;

ALLOXAN DIABETES MELLITUS; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; BODY WEIGHT; CONTROLLED STUDY; DIABETES MELLITUS; DRUG ACTIVITY; DRUG MECHANISM; DRUG POTENTIATION; DRUG SCREENING; FEMALE; GLUCOSE BLOOD LEVEL; GLUCOSE UTILIZATION; HERB DRUG INTERACTION; MALE; MOUSE; NONHUMAN; ORAL GLUCOSE TOLERANCE TEST;

EID: 70449623331     PISSN: 16067754     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (25)

1. Shah S, Bodhankar S, Bhonde R, Mohan V. Combinative therapeutic approach for better blood sugar level control in alloxan diabetic mice. Int J Diab 2006; 14: 104-105. (Pubitemid 46785228)
2. Basch E, Ulbricht C, Kuo G, et al. Therapeutic Applications of Fenugreek. Altern Med Rev 2003; 8: 20-27.
3. Al-Habori M, Raman A. Antidiabetic and hypocholesterolaemic effects of fenugreek. Phytother Res 1998; 12: 233-242.
4. Narender T, Puri, A, Shweta, Khaliq T, Saxena R, Bhatia G, Chandra R. 4-Hydroxyisoleucine and unusual amino acid as antidysplipidemic and antihyperglycemic agent. Bioorg Med Chem Lett 2006; 16: 293-296. (Pubitemid 41680616)
5. Sauvaire Y, Petit P, Broca C, et al. 4 -hydroxyisoleucine: a novel amino acid potentiator of insulin secretion. Diabetes 1998; 47: 206-210 (Pubitemid 28079975)
6. Broca C, Breil V, Cruciani-Guglielmacci C, et al. The insulinotropic agent ID1101 (4-hydroxyisoleucine) activates insulin signaling in rat. Am J Physiol Endocrinol Metab 2004; 287: E463-E471. (Pubitemid 39095880)
7. Broca C, Manteghetti M, Gross R, et al. 4-hydroxyisoleucine: effects of synthetic and natural analogues on insulin secretion. Eur J Pharmacol 2000; 390:339-345. (Pubitemid 30119951)
8. Shah SN, Bodhankar SL, Badole SL, et al. Effect of trigonelline: an active compound from Trigonella foenum-graecum Linn. in alloxan induced diabetic mice. J Cell Tissue Res 2006; 6:585-590
9. Mishkinsky J, Joseph B, Sulman FG. Hypoglycaemic effect of trigonelline. Lancet 1967; 2: 1311-1312.
10. Shani J, Goldschmied A, Joseph B, et al. Hypoglycaemic effect of Trigonella foenum-graecum and Lupinus Termis (Leguminosae) seeds and their major alkaloids in alloxan diabetic and normal rats. Arch Int de Pharmacodyn et de therapie 1974; 210: 27-37.
11. Clifford IB, Caroline D. Traditional plant medicines as treatments for diabetes. Diabet Care 1989; 12:553-564.
12. Al-Shamaony L, Shahba M, Al-Khazraji, Twaij, HAA. Hypoglycaemic effect of Artemisia herba alba.II. Effect of valuable extract on some blood parameters in diabetic animals. J Ethnopharmacol 1994; 43:167-171.
13. Nadakarni KM. Trigonella foenum graecum In: Nadkarni KM editor. Indian Materia Medica. Bombay: Popular Prakashan Pvt. Ltd; 1982: 1240-1243.
14. Ghafghazi T, Sheriat HS, Dastmalchi T. Antagonism of cadmium and alloxan-induced hyperglycemia in rats by Trigonella foenum-graecum. Pahlavi Med J 1977; 8:14.
15. Ravikumar P, Anuradha CV. Effect of fenugreek seeds on blood lipid peroxidation and antioxidants in diabetic rats. Phytother Res 1999; 13: 197-201. (Pubitemid 29229445)
16. Gupta D, Raju J, Baquer NZ. Modulation of some gluconeogenic enzyme activities in diabetic rat liver and kidney: effect of antidiabetic compounds. Ind J Exp Biol 1999; 37: 196-201.
17. Genet S, Kale RK, Baquer NZ. Effect of vanadate, insulin and fenugreek (Trigonella foenum-graecum) on creatine kinase levels in tissues of diabetic rat. Ind J Exp Biol 1999; 37: 200-204.
18. Raju J, Gupta D, Rao AR, Yadava PK, Baquer NZ. Trigonella foenum graecum (fenugreek) seed powder improves glucose homeostasis in alloxan diabetic rat tissues by reversing the altered glycolytic, gluconeogenic and lipogenic enzymes. Mol Cell Biochem 2001; 224: 45-49.
19. th edition, 2001; 1701-1703.
20. Lehmann JM, Moore LB, Smith-Oliver TA, et al. An antidiabetic thiazolidinedione is a high affinity ligand for peroxisome proliferator- activated receptor. J Biol Chem 1995; 270: 12953-12956.
21. Saltiel AR, Olefsky JM. Thiazolidinediones in the treatment of insulin resistance and type II diabetes. Diabetes 1996; 45:1661-1669. (Pubitemid 26398943)
22. Okuno A,Tamemoto H,Tobe K, et al. Troglitazone increases the number of small adipocytes without the change of white adipose tissue mass in obese Zucker rats. J Clin Invest 1998;101: 1354-1361.
23. Willson TM, Brown PJ, Sternbach DD, et al. The PPARs: from orphan receptors to drug discovery. J Med Chem 2000; 43: 527-550. (Pubitemid 30127149)
24. Sauvaire Y, Petit P, Broca C, et al. 4 -hydroxyisoleucine: a novel amino acid potentiator of insulin secretion. Diabetes 1998; 47: 206-210. (Pubitemid 28079975)
25. McWhorter LS. Biological Complementary Therapies: A Focus on Botanical Products in Diabetes. Diab Spectrum 2001; 14: 199-208.